Paper

Subject Categories: Cardiovascular and pulmonary pharmacology

British Journal of Pharmacology (2005) 146, 568–575. doi:10.1038/sj.bjp.0706347; published online 8 August 2005

Intracellular pathways triggered by the selective FLT-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxia

Lydia Bellik1, Maria Cristina Vinci1, Sandra Filippi1, Fabrizio Ledda1 and Astrid Parenti1

1Laboratory of Vascular Pharmacology, Department of Preclinical and Clinical Pharmacology, University of Florence, Viale G. Pieraccini, 50139, Florence, Italy

Correspondence: Astrid Parenti, E-mail: astrid.parenti@unifi.it

Received 22 April 2005; Revised 16 June 2005; Accepted 22 June 2005; Published online 8 August 2005.

Top

Abstract

  1. We have previously shown that hypoxia makes vascular smooth muscle cells (VSMCs) responsive to placental growth factor (PlGF) through the induction of functional fms-like tyrosine kinase (Flt-1) receptors. The aim of this study was to investigate the molecular mechanisms involved in the PlGF effects on proliferation and contraction of VSMCs previously exposed to hypoxia (3% O2).
  2. In cultured rat VSMCs exposed to hypoxia, PlGF increased the phosphorylation of protein kinase B (Akt), p38 and STAT3; activation of STAT3 was higher than that of other kinases. In agreement with this finding, the proliferation of hypoxia-treated VSMCs in response to PlGF was significantly impaired by the p38 and the phosphatidylinositol 3-kinase inhibitors SB202190 and LY294002, respectively, and was almost completely prevented by AG490, a janus tyrosine kinase (JAK)/signal transducer and activator of transcription (STAT) inhibitor.
  3. Since hypoxia was able to reverse the vasorelaxant effect of PlGF into a vasoconstrictor response, the mechanism of this latter effect was also investigated. Significant Flt-1 activity was measured in isolated preparations from rat aorta exposed to hypoxia. Inhibitors of mitogen-activated protein kinase kinase, Akt and STAT3 induced a modest inhibition of the vasoconstrictor response to PlGF, while the p38 inhibitor SB202190 markedly impaired the PlGF-induced contractile response. These effects were selectively mediated by Flt-1 without any involvement of foetal liver kinase-1 receptors.
  4. These data are the first evidence that different intracellular pathways activated by Flt-1 receptor in VSMCs are involved in diverse biological effects of PlGF: while mitogen activated protein kinase kinase/extracellular signal regulated kinase1/2 and JAK/STAT play a role in VSMC proliferation, p38 is involved in VSMC contraction. These findings may highlight the role of PlGF in vascular pathology.

Keywords:

Placental growth factor (PlGF), fms-like tyrosine kinase (Flt-1), hypoxia, vascular smooth muscle cell (VSMC) proliferation, vascular tone, p38, STAT3

Abbreviations:

Akt, protein kinase B; ERK1/2, extracellular signal regulated kinase1/2; Flk-1, foetal liver kinase-1; Flt-1, fms-like tyrosine kinase; HIF, hypoxia-inducible factor; JAK, janus tyrosine kinase; KDR, kinase insert domain protein receptor; MAPK, mitogen activated protein kinase; MEK, mitogen-activated protein kinase kinase; PI3K, phosphatidylinositol 3-kinase; PKC, protein kinase C; STAT, signal transducer and activator of transcription; VEGF-A, vascular endothelial growth factor-A; VSMCs, vascular smooth muscle cells

Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

Extra navigation

.

natureproducts


ADVERTISEMENT